These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28983339)

  • 21. PLAG Exerts Anti-Metastatic Effects by Interfering with Neutrophil Elastase/PAR2/EGFR Signaling in A549 Lung Cancer Orthotopic Model.
    Kim GT; Hahn KW; Yoon SY; Sohn KY; Kim JW
    Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32121107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of inorganic mesoporous carriers on 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol-loaded solid self-emulsifying drug delivery system: Physicochemical characterization and bioavailability in rats.
    Kim DS; Yang ES; Yong CS; Youn YS; Oh KT; Li DX; Kim JO; Jin SG; Choi HG
    Colloids Surf B Biointerfaces; 2017 Dec; 160():331-336. PubMed ID: 28957774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timing of chemotherapy-induced neutropenia: the prognostic factor in advanced pancreatic cancer patients treated with gemcitabine / gemcitabine-based chemotherapy.
    Chen Y; Shi Y; Yan H; Wang YR; Dai GH
    Oncotarget; 2017 Sep; 8(39):66593-66600. PubMed ID: 29029540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PLAG enhances macrophage mobility for efferocytosis of apoptotic neutrophils via membrane redistribution of P2Y2.
    Kim GT; Hahn KW; Sohn KY; Yoon SY; Kim JW
    FEBS J; 2019 Dec; 286(24):5016-5029. PubMed ID: 31714686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of EC-18, a synthetic monoacetyldiglyceride (1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol), in rat and mouse plasma by liquid-chromatography/tandem mass spectrometry.
    Ryu HM; Jeong YS; Yim CS; Lee JH; Chung SJ
    J Pharm Biomed Anal; 2017 Apr; 137():155-162. PubMed ID: 28122294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
    Crawford J; Ozer H; Stoller R; Johnson D; Lyman G; Tabbara I; Kris M; Grous J; Picozzi V; Rausch G
    N Engl J Med; 1991 Jul; 325(3):164-70. PubMed ID: 1711156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining the impact of the use of granulocyte colony stimulating factors on the incidence of chemotherapy-induced neutropenia in patients with gynecologic malignancies.
    Julius JM; Hammerstrom A; Wei C; Rajesh R; Bodurka DC; Kurian S; Smith JA
    J Oncol Pharm Pract; 2017 Mar; 23(2):121-127. PubMed ID: 26692242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of 1-Palmitoyl-2-Linoleoyl-3-Acetyl-Rac-Glycerol-Loaded Self-Emulsifying Granule and Solid Self-Nanoemulsifying Drug Delivery System: Powder Property, Dissolution and Oral Bioavailability.
    Kim DS; Kim JS; Lim SJ; Kim JO; Yong CS; Choi HG; Jin SG
    Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31426411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
    J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.
    Huang W; Liu J; Zeng Y; Wu F; Li N; Chen K; Hong Y; Wang L; Zhen H; Lin L
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):607-613. PubMed ID: 30043207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
    Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized study of dose or schedule modification of granulocyte colony-stimulating factor in platinum-based chemotherapy for elderly patients with lung cancer.
    Oshita F; Yamada K; Nomura I; Tanaka G; Ikehara M; Noda K
    Oncol Rep; 2001; 8(4):861-6. PubMed ID: 11410799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer].
    Xu B; Tian F; Yu J; Song Y; Shi J; Zhang B; Zhang Y; Yuan Z; Wu Q; Zhang Q; Nan K; Sun Q; Li W; Hu J; Bi J; Meng C; Dai H; Jiang H; Yue S; Cao B; Sun Y; Wang S; Tong Z; Shen P; Wu G; Tang L; Deng Y; Jia L; Shen K; Zhuang W; Xie X; Wu Y; Chen L
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):23-7. PubMed ID: 26796802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic administration of granulocyte colony-stimulating factor when monocytopenia appears lessens neutropenia caused by chemotherapy for lung cancer.
    Oshita F; Yamada K; Nomura I; Tanaka G; Ikehara M; Noda K
    Am J Clin Oncol; 2000 Jun; 23(3):278-82. PubMed ID: 10857893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ameliorating effect of 1-palmitoyl-2-linoleoyl-3-acetylglycerol on scopolamine-induced memory impairment via acetylcholinesterase inhibition and LTP activation.
    Jeon SJ; Kim B; Park HJ; Zhang J; Kwon Y; Kim DH; Ryu JH
    Behav Brain Res; 2017 May; 324():58-65. PubMed ID: 28137622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between severity and duration of chemotherapy-induced neutropenia and risk of infection among patients with nonmyeloid malignancies.
    Li Y; Klippel Z; Shih X; Reiner M; Wang H; Page JH
    Support Care Cancer; 2016 Oct; 24(10):4377-83. PubMed ID: 27278272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study.
    Kasi PM; Kotani D; Cecchini M; Shitara K; Ohtsu A; Ramanathan RK; Hochster HS; Grothey A; Yoshino T
    BMC Cancer; 2016 Jul; 16():467. PubMed ID: 27412464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of EC-18, a synthetic monoacetyldiglyceride on lung inflammation in a murine model induced by cigarette smoke and lipopolysaccharide.
    Shin IS; Ahn KS; Shin NR; Lee HJ; Ryu HW; Kim JW; Sohn KY; Kim HJ; Han YH; Oh SR
    Int Immunopharmacol; 2016 Jan; 30():62-68. PubMed ID: 26655742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.